TLDR Trichofolliculoma has specific cytokeratin patterns that help in its diagnosis.
The document presented a case report on trichofolliculoma, a rare benign hair follicle tumor, and included an immunohistochemical study focusing on cytokeratins. The study was conducted by a team from various departments in Japan, including dermatology, plastic and reconstructive surgery, and pathology. The findings highlighted the specific expression patterns of cytokeratins in trichofolliculoma, contributing to a better understanding of its histopathological characteristics. This research provided valuable insights into the diagnosis and differentiation of trichofolliculoma from other skin lesions.
17 citations
,
June 2017 in “British Journal of Dermatology” The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.
7 citations
,
March 2017 in “Journal of dermatology” The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.
16 citations
,
July 2021 in “Histopathology” New markers and pathways have been found in skin tumors, helping better understand and diagnose them.
July 2025 in “Clinical Dermatology Review” A rare family case of multiple benign hair follicle tumors was identified, highlighting the need to distinguish them from similar conditions.
19 citations
,
September 2016 in “Journal of the European Academy of Dermatology and Venereology” Trichofolliculoma is a unique benign tumor mainly affecting middle-aged adults' faces, often misdiagnosed without histopathology.
